2Reijke TM,Kurth KH,Sylvester RJ,et al.Bacillus Calmette-Guerin versus epirubicin for primary,secondary or concurrent carcinoma in situ of the bladder:results of a European Organization for the Research and Treatment of Cancer-Genito-Urinary Group Phase Ⅲ Trial.J Urol,2005,173:405-409.
3Di Stasi SM,Giannantoni A,Stephen RL,et al.Intravesical electromotive mitomycin C versus passive transport mitomycin C for high risk superficial bladder cancer:a prospective randomized study.J Urol,2003,170:777-782.
4Kaasinen E,Wijkstrom H,Malmstrom PU,et al.Alternating mitomycin C and BCG instillations versus BCG alone in treatment of carcinoma in situ of the urinary bladder:a nordic study.Eur Urol,2003,43:637-645.
5Tozawa K,Okamura T,Sasaki S,et al.Intravesical combined chemoimmunotherapy with epirubicin and bacillus Calmette-Guerin is not indicated for superficial bladder cancer.Urol Int,2001,67:289-292.
6Sekine H,Ohya K,Kojima SI,et al.Equivalent efficacy of mitomycin C plus doxorubicin instillation to bacillus Calmette-Guerin therapy for carcinoma in situ of the bladder.Int J Urol,2001,8:483-486.
7Takashi M,Shimoji T,Murase T,et al.Intravesical bacillus Calmette-Guerin (Tokyo 172 strain) therapy for carcinoma in situ of the bladder.Int Urol Nephrol,1997,29:557-563.
8Melekos MD,Zarakovitis I,Dandinis K,et al.BCG versus epirubicin in the prophylaxis of multiple superficial bladder tumours:results of a prospective randomized study using modified treatment schemes.Int Urol Nephrol,1996,28:499-509.
9Rintala E,Jauhiainen K,Rajala P,et al.Alternating mitomycin C and bacillus Calmette-Guerin instillation therapy for carcinoma in situ of the bladder.The Finnbladder Group.J Urol,1995,154:2050-2053.
10Bercovich E,Deriu M,Manferrari F,et al.BCG vs.BCG plus recombinant alpha-interferon 2b in superficial tumors of the bladder.Arch Ital Urol Androl,1995,67:257-260.
